Discordance Between Systemic Lupus Erythematosus Disease Activity Index Domain Weights and Their Association With Organ Damage Accrual - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Discrepancies in Domain Weights of the Systemic Lupus Erythematosus Disease Activity Index and Their Relationship with Accumulation of Organ Damage

  • By

  • Kevin Zhang

  • Eric F. Morand

  • Sarah E. Boyd

  • François Petitjean

  • Alberta Hoi

  • Rachel Koelmeyer

  • Iolanda Miceli

  • Julie A. Monk

  • Hieu T. Nim

  • May 12, 2026

Share

Clinical Scorecard: Discrepancies in Domain Weights of the Systemic Lupus Erythematosus Disease Activity Index and Their Relationship with Accumulation of Organ Damage

At a Glance

CategoryDetail
ConditionSystemic Lupus Erythematosus (SLE)
Key MechanismsAssociation between disease activity measurements and organ damage accrual.
Target PopulationPatients with Systemic Lupus Erythematosus attending a single center.
Care SettingLongitudinal clinical data collection in a specialized lupus clinic.

Key Highlights

  • SLEDAI-2K total scores are modestly predictive of organ damage accrual.
  • Domain weightings of SLEDAI-2K are discordant with organ damage accrual risk.
  • Lower-weighted SLEDAI-2K domains are positively associated with damage.
  • Higher-weighted domains show negative or no association with damage transition.
  • Prednisolone use is significantly associated with damage transition.

Guideline-Based Recommendations

Diagnosis

  • Use SLEDAI-2K for assessing disease activity in SLE.

Management

  • Aim to control disease activity to prevent organ damage accrual.

Monitoring & Follow-up

  • Assess organ damage using the SLICC/ACR Damage Index annually.

Risks

  • Monitor for organ damage accrual associated with disease activity.

Patient & Prescribing Data

Patients aged ≥18 years fulfilling the 1982 ACR revised criteria for SLE.

Prednisolone use is linked to increased risk of organ damage.

Clinical Best Practices

  • Refine disease activity measures based on associations with outcomes.
  • Conduct regular assessments of disease activity and organ damage.

Related Resources & Content

Original Source(s)

Related Content